Description:

ACNS0122 Consolidation Worksheet NCT00047320 Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BD4225D7-47E1-0D12-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BD4225D7-47E1-0D12-E034-0003BA12F5E7

Keywords:
Versions (5) ▾
  1. 8/26/12
  2. 1/8/15
  3. 1/9/15
  4. 1/9/15
  5. 7/5/15
Uploaded on:

July 5, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

ACNS0122 Consolidation Worksheet NCT00047320

No Instruction available.

  1. StudyEvent: ACNS0122 Consolidation Worksheet
    1. No Instruction available.
Reporting period
cm
Kg
Tumor Evaluation
Type [imaging studies]
Disease Status
Was the patient's disease status evaluated during this reporting interval?
Type of response
Evaluations
Was a Neurologic assessment done?
Was endocrinologic evaluation done?
Significant Events During This Reporting Period
Were there any dose modifications or additions/omissions to protocol treatment?
Has a new primary cancer or MDS been diagnosed that has not been previously reported?
Is patient off protocol therapy?
Reason treatment ended
Life status at the end of this reporting period
Was patient unable to be contacted for current scheduled follow-up?
Was the patient enrolled on another COG therapeutic study at the end of the reporting period?
Did the patient withdraw consent for follow-up at the end of the reporting period?
Did the patient receive non-protocol anti-cancer treatment during this reporting period?
Type [non-protocol treatment] (Types of Treatment)
Treatment Plan After This Treatment Period
What is the patient's treatment plan after chemotherapy?
Toxicities
Attribution
Adverse Drug Experience?
Comments
Ccrr Module For Acns0122 Consolidation Worksheet